The current price of AGIO is $28.27 — it has decreased by 9.91% since the previous close. Data as of Nov 5, 2026.
AGIO is down 10.05% over the past week, down 9.54% over the past month and down 30.21% over the past year. The price is below its 200-day moving average of $31.75.
Of the 10 analysts covering Agios Pharmaceuticals, Inc., 7 rate it a buy and 3 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Agios Pharmaceuticals, Inc. has a market capitalization of $1.69B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
Agios Pharmaceuticals, Inc. has not paid any dividends over the past year.
Companies most comparable to Agios Pharmaceuticals, Inc. include Mirum Pharmaceuticals, Inc., PTC Therapeutics, Inc., Disc Medicine, Inc., BioCryst Pharmaceuticals, Inc. and Ultragenyx Pharmaceutical Inc.
In the latest trading session AGIO moved between $27.57 and $31.19, a range of 12.82% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Agios Pharmaceuticals, Inc. shows a strong sell rating today and a strong sell rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Agios Pharmaceuticals, Inc. is strong sell. Technical ratings are indicators, not investment advice.
Over the past 52 weeks AGIO has traded between $22.24 and $46.00. The current price is 38.54% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.